Two papillary renal cell carcinomas of different origin following renal transplantation (Case report)

被引:4
作者
Gerth, Hans-Ulrich [1 ]
Pohlen, Michele [2 ]
Thoennissen, Nils-Heinrich [2 ]
Suwelack, Barbara [1 ]
Pavenstaedt, Hermann-Josef [1 ]
Stoerkel, Stefan [3 ]
Abbas, Mahmoud [4 ]
Spieker, Tilmann [4 ]
Thoelking, Gerold [1 ]
机构
[1] Univ Munster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, D-48149 Munster, Germany
[2] Univ Hosp Munster, Dept Med A Hematol Oncol, D-48149 Munster, Germany
[3] Helios Hosp, Dept Pathol, D-42283 Wuppertal, Germany
[4] Univ Hosp Munster, Dept Pathol, Munster, Germany
关键词
nephrectomy; renal cell carcinoma; renal transplantation; CANCER-RISK; KIDNEY;
D O I
10.3892/ol.2012.704
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Papillary renal cell carcinoma (PRCC) is a rare malignant tumor entity compared to common clear cell renal carcinoma. In the present study, we report a patient who was diagnosed with PRCC twice and successfully treated each time following renal transplantation. The first PRCC was located in the left native kidney two years following transplantation, and the second PRCC was diagnosed in the allograft 13 years following transplantation. The two tumors were completely removed by surgery in stage I of the disease with sufficient conservation of the allograft function. Notably, the tumors had a different origin as indicated by the microsatellite analysis, which reflects the exceptional course of the case. Risk factors for PRCC were identified in our patient. We concluded that high-risk candidates for malignancies in renal transplant recipients should receive shorter ultrasonic screening intervals, which may facilitate early tumor detection and improve outcome rates.
引用
收藏
页码:80 / 82
页数:3
相关论文
共 15 条
  • [1] De novo multifocal renal cell carcinoma in the renal allograft
    Alexander, Mariam P.
    Farag, Youssef M. K.
    Mittal, Bharati V.
    Rennke, Helmut G.
    Tullius, Stefan G.
    Singh, Ajay K.
    [J]. KIDNEY INTERNATIONAL, 2009, 75 (01) : 111 - 114
  • [2] Cancer risk in patients on dialysis and after renal transplantation
    Birkeland, SA
    Lokkegaard, H
    Storm, HH
    [J]. LANCET, 2000, 355 (9218) : 1886 - 1887
  • [3] Hoshida Y, 1997, INT J CANCER, V71, P517, DOI 10.1002/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO
  • [4] 2-X
  • [5] Renal cell carcinoma of native kidneys in renal transplant recipients
    Ishikawa, N
    Tanabe, K
    Tokumoto, T
    Koga, S
    Okuda, H
    Nakazawa, H
    Takahasi, K
    Toma, H
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3156 - 3158
  • [6] Cancer after kidney transplantation in the United States
    Kasiske, BL
    Snyder, JJ
    Gilbertson, DT
    Wang, CC
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) : 905 - 913
  • [7] Malignancy in renal transplantation
    Morath, C
    Mueller, M
    Goldschmidt, H
    Schwenger, V
    Opelz, G
    Zeier, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06): : 1582 - 1588
  • [8] PENN I, 1995, TRANSPLANTATION, V59, P480
  • [9] Oncologic Long-term Outcome of Elective Nephron-sparing Surgery Versus Radical Nephrectomy in Patients With Renal Cell Carcinoma Stage pT1b or Greater in a Matched-pair Cohort
    Roos, Frederik C.
    Brenner, Walburgis
    Mueller, Melanie
    Schubert, Claudia
    Jaeger, Wolfgang J.
    Thueroff, Joachim W.
    Hampel, Christian
    [J]. UROLOGY, 2011, 77 (04) : 803 - 808
  • [10] Renal cell carcinoma of the grafted kidney:: How to improve screening and graft tracking
    Roupret, M
    Peraldi, MN
    Thaunat, O
    Chrétien, Y
    Thiounn, N
    Dufour, B
    Kreis, H
    Méjean, A
    [J]. TRANSPLANTATION, 2004, 77 (01) : 146 - 148